Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG

Coronavirus disease 2019 (COVID-19) convalescent plasma has emerged as a promising therapy and has been granted Emergency Use Authorization by the US Food and Drug Administration for hospitalized COVID-19 patients. We recently reported results from interim analysis of a propensity score–matched stud...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Pathol
Auteurs principaux: Salazar, Eric, Christensen, Paul A., Graviss, Edward A., Nguyen, Duc T., Castillo, Brian, Chen, Jian, Lopez, Bevin V., Eagar, Todd N., Yi, Xin, Zhao, Picheng, Rogers, John, Shehabeldin, Ahmed, Joseph, David, Masud, Faisal, Leveque, Christopher, Olsen, Randall J., Bernard, David W., Gollihar, Jimmy, Musser, James M.
Format: Artigo
Langue:Inglês
Publié: American Society for Investigative Pathology. Published by Elsevier Inc. 2021
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7609241/
https://ncbi.nlm.nih.gov/pubmed/33157066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2020.10.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires